State efforts to grow pot industries clash with federal law
New Jersey’s Department of Health announced Monday that it will significantly boost the number of licenses it distributes in hopes of expanding the state’s medical marijuana program.
But accessing medical marijuana remains difficult for some patients, even in states that hope to permit its use, cannabis advocates say. Because cannabis remains classified as a Schedule 1 drug under the Controlled Substances Act, the Food and Drug Administration has not approved it to reduce pain, treat anxiety or provide other much-touted health benefits.